mucus relief maximum strength (55910-732)

Drug Facts

Product Profile

Brand Name mucus relief maximum strength

Generic Name guaifenesin

Labeler dolgencorp, inc. (dollar general & rexall)

Dosage Form TABLET

Routes

ORAL

Active Ingredients

guaifenesin 1200 mg/1

Manufacturer

Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)

Identifiers & Regulatory

Product NDC 55910-732

Product ID 55910-732_cd9b51f9-7869-4ef4-ace0-5d3036da152e

Product Type HUMAN OTC DRUG

Marketing Category ANDA

Application Number ANDA207342

Marketing Start 2019-03-31

Marketing End 2027-02-01

Pharmacologic Class

Established (EPC)

expectorant [epc]

Physiologic Effect

decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55910732

Hyphenated Format 55910-732

Supplemental Identifiers

RxCUI

310621

UPC

0359726733151

UNII

495W7451VQ

NUI

N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mucus relief maximum strength (source: ndc)

Generic Name guaifenesin (source: ndc)

Application Number ANDA207342 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

1200 mg/1

source: ndc

Packaging

14 BLISTER PACK in 1 CARTON (55910-732-14) / 1 TABLET in 1 BLISTER PACK

source: ndc

Packages (1)

55910-732-14 14 BLISTER PACK in 1 CARTON (55910-732-14) / 1 TABLET in 1 BLISTER PACK

Ingredients (1)

guaifenesin (1200 mg/1)

Linked Drug Pages (1)

Mucus Relief Maximum Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "cd9b51f9-7869-4ef4-ace0-5d3036da152e", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0359726733151"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["3ee82152-7c6f-4d93-909d-e1c50eee27e5"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 BLISTER PACK in 1 CARTON (55910-732-14)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55910-732-14", "marketing_end_date": "20270201", "marketing_start_date": "20190331"}], "brand_name": "Mucus Relief Maximum Strength", "product_id": "55910-732_cd9b51f9-7869-4ef4-ace0-5d3036da152e", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "55910-732", "generic_name": "Guaifenesin", "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucus Relief", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA207342", "marketing_category": "ANDA", "marketing_end_date": "20270201", "marketing_start_date": "20190331"}